ChronicleBio

Growth Financing · August 2026 · Investor & Advisor

Cereona built the investment narrative around disease heterogeneity — redefining the market size and applications for the company’s multi-omic stack — and developed the use of proceeds for the round across data generation and advancing therapeutic assets.

Cereona ran a tight process with a narrow set of strategically aligned investors and introduced institutional capital to the round. Cereona’s founder invested alongside the client.